Document is current
Any future updates will be listed below
-
Authors
Vasileiou, Georgia https://orcid.org/0000-0002-1993-1134
Costa, Maria J.
Long, Christopher
Wetzler, Iris R.
Hoyer, Juliane
Kraus, Cornelia
Popp, Bernt
Emons, Julius
Wunderle, Marius
Wenkel, Evelyn
Uder, Michael
Beckmann, Matthias W.
Jud, Sebastian M.
Fasching, Peter A.
Cavallaro, Alexander
Reis, André
Hammon, Matthias
-
Funding
Funding for this research was provided by:
Bundesministerium für Wirtschaft und Energie (01MT14001C, 01MT14001C, 01MT14001C, 01MT14001C)
H2020 Marie Skłodowska-Curie Actions (No. 752652)
- License Information
-
More Information
Article History
Received: 2 April 2020
Accepted: 10 July 2020
First Online: 29 July 2020
Ethics approval and consent to participate
: The study was approved by the Ethical Committee of the Medical Faculty of the Friedrich-Alexander-Universität Erlangen-Nürnberg. Informed written consent was obtained from all affected individuals.
: Not Applicable.
: M.J.C. and C. L. are employees of Siemens Healthcare. J.E. reports honaria from Eisai. P.A.F reports grants from Novartis, Cepheid, and Biontech and personal fees from Novartis, Roche, Pfizer, Celgene, Daiichi-Sankyo, TEVA, Astra Zeneca, Merck Sharp & Dohme, Myelo Therapeutics, Macrogenics, Eisai and Puma. The other authors declare no competing financial interests.
